Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu, et al.
Cell (2017) Vol. 170, Iss. 3, pp. 548-563.e16
Open Access | Times Cited: 1678

Showing 1-25 of 1678 citing articles:

Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten, Sergei I. Grivennikov
Immunity (2019) Vol. 51, Iss. 1, pp. 27-41
Open Access | Times Cited: 2745
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares, Mohamad Y. Fares, Hussein H. Khachfe, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1782
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller, Michal Barzily-Rokni, Tal Danino, et al.
Science (2017) Vol. 357, Iss. 6356, pp. 1156-1160
Open Access | Times Cited: 1385
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1305
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos, Nikolaos Spyrou, Christos S. Mantzoros, et al.
Metabolism (2018) Vol. 92, pp. 121-135
Open Access | Times Cited: 1237
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska, et al.
Science (2017) Vol. 358, Iss. 6369, pp. 1443-1448
Open Access | Times Cited: 1178
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
George Hajishengallis, Triantafyllos Chavakis
Nature reviews. Immunology (2021) Vol. 21, Iss. 7, pp. 426-440
Open Access | Times Cited: 1010
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong, Jun Yu
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 690-704
Closed Access | Times Cited: 973
The microbiome, cancer, and cancer therapy
Beth A. Helmink, Md Abdul Wadud Khan, Amanda Hermann, et al.
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 377-388
Closed Access | Times Cited: 958
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Caitlin A. Brennan, Wendy S. Garrett
Nature Reviews Microbiology (2018) Vol. 17, Iss. 3, pp. 156-166
Open Access | Times Cited: 890
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 872
The Intestinal Microbiota in Colorectal Cancer
Herbert Tilg, Timon E. Adolph, Romana R. Gerner, et al.
Cancer Cell (2018) Vol. 33, Iss. 6, pp. 954-964
Open Access | Times Cited: 637
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel, Yuting Ma, Didier Raoult, et al.
Science (2018) Vol. 359, Iss. 6382, pp. 1366-1370
Open Access | Times Cited: 620
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Mingyang Song, Andrew T. Chan, Jun Sun
Gastroenterology (2019) Vol. 158, Iss. 2, pp. 322-340
Open Access | Times Cited: 585
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer
Aikun Fu, Bingqing Yao, Tingting Dong, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1356-1372.e26
Open Access | Times Cited: 580
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
Liye Wang, Kwang Bog Cho, Yan Li, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5758-5758
Open Access | Times Cited: 551
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo, Siew C. Ng
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 501
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Winnie Fong, Qing Li, Jun Yu
Oncogene (2020) Vol. 39, Iss. 26, pp. 4925-4943
Open Access | Times Cited: 466
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 810-817
Open Access | Times Cited: 445
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Lishay Parhi, Tamar Alon‐Maimon, Asaf Sol, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 444
A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice
Lijuan Wang, Lei Tang, Yiming Feng, et al.
Gut (2020) Vol. 69, Iss. 11, pp. 1988-1997
Open Access | Times Cited: 438
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 6, pp. 382-396
Closed Access | Times Cited: 436
The Intestinal Microbiota and Colorectal Cancer
Yiwen Cheng, Zongxin Ling, Lanjuan Li
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 395
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1
Mara Roxana Rubinstein, Jung Eun Baik, Stephen M. Lagana, et al.
EMBO Reports (2019) Vol. 20, Iss. 4
Open Access | Times Cited: 394
Adipocyte and lipid metabolism in cancer drug resistance
Yihai Cao
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3006-3017
Open Access | Times Cited: 386
Page 1 - Next Page

Scroll to top